Therapies for acute renal failure
CA 2289123 A1 · Owner: Vukicevic, Slobodon · Inventors: Sampath, Kuber T.; Vukicevic, Slobodon; Cohen, Charles M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides methods for the treatment and pharmaceuticals , for use in the treatment of mammalian subjects in, or at risk of acute renal , failure, or subject to, or at risk of inflammation, neutrophil-mediated cell damage, and apoptosis resulting from tissue damage or injury. The methods involve the administration of certain proteins of the osteogenic protein/bone morphogenetic protein (OP/BMP) family within the TGF-.beta. superfamily of proteins.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 5, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 5, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 5, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.